Our data indicate that there is no increased innate immune response of glia in ALS: using the established model of SOD1 overexpression in human astrocytes, we did not observe increased pro-inflammatory response after LPS treatment and this result is similar when OM cells from healthy donors and those from ALS patients are compared. This evidence concerns the gene SOD1 and ocular melanoma.